To include your compound in the COVID-19 Resource Center, submit it here.

Musculoskeletal

INDICATION: Myotonic dystrophy type 1 (DM1)

Patient sample and mouse studies suggest activating AMPK or inhibiting mTORC1 could help treat DM1. In

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE